TY  - JOUR
AU  - Masana, Luis
AU  - Ibarretxe, Daiana
AU  - Rodriguez-Borjabad, Cèlia
AU  - Plana, Nuria
AU  - Valdivielso, Pedro
AU  - Pedro-Botet, Juan
AU  - Civeira, Fernando
AU  - Lopez-Miranda, Jose
AU  - Guijarro, Carlos
AU  - Mostaza, Jose
AU  - Pinto, Xavier
PY  - 2019
DO  - 10.1016/j.atherosclerosis.2019.06.905
UR  - http://hdl.handle.net/10668/14172
T2  - Atherosclerosis
AB  - The introduction of singular therapies, such as proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i), to lower high cholesterol levels requires better classification of patients eligible for intensive lipid lowering therapy. According to...
LA  - en
PB  - Elsevier
KW  - Diagnosis
KW  - Familial combined hyperlipidaemia
KW  - Familial hypercholesterolemia
KW  - PCSK9 inhibitors
KW  - Polygenic familial hypercholesterolemia classification
KW  - Genetic Predisposition to Disease
KW  - Genetic Testing
KW  - Genome-Wide Association Study
KW  - Humans
KW  - Hyperlipoproteinemia Type II
KW  - Phenotype
KW  - Spain
TI  - Toward a new clinical classification of patients with familial hypercholesterolemia: One perspective from Spain.
TY  - research article
VL  - 287
ER  -